Circuit re ‘ we should have been at $30 ‘ Why exactly .... because some on this board who should know better .. opined as such ? Does AMRN have FDA approval for the R-It indication Does AMRN have the method of use or composition patients for Vascepa to reduce MACE in CAD patients on statins Does AMRN have the sales ... etc etc Lay out your case for why we should be at $30 Thx Kiwi
"Why they update target every month? One thing I can tell you is that analyst is just a job, he/she needs to be able to charge some hours to amrn topic every month. There is really no incentive for him to do a perfect job the first place."
Likely trying to earn amrn's biz if amrn decides to do an offering. HCW does a lot of these.